Stay updated with breaking news from Solid Biosciences Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) insider Jessie Hanrahan sold 4,879 shares of Solid Biosciences stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $13,563.62. Following the transaction, the insider now owns 6,983 shares of the company’s […]
Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Solid Biosciences […]
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 21,500 shares, a decrease of 27.4% from the September 30th total of 29,600 shares. Based on an average trading volume of 23,700 shares, […]
Great Point Partners LLC acquired a new stake in shares of Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 210,405 shares of the company’s stock, valued at approximately $997,000. Great Point Partners LLC owned […]
Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Stock analysts at Leerink Partnrs boosted their Q3 2023 earnings per share (EPS) estimates for shares of Solid Biosciences in a report released on Wednesday, August 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings per share of ($1.05) for the quarter, […]